These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 28543567

  • 21. Role of TGR5 (GPBAR1) in Liver Disease.
    Keitel V, Häussinger D.
    Semin Liver Dis; 2018 Nov; 38(4):333-339. PubMed ID: 30357770
    [Abstract] [Full Text] [Related]

  • 22. Autophagy promotes hepatic cystogenesis in polycystic liver disease by depletion of cholangiocyte ciliogenic proteins.
    Masyuk AI, Masyuk TV, Trussoni CE, Pirius NE, LaRusso NF.
    Hepatology; 2022 May; 75(5):1110-1122. PubMed ID: 34942041
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
    Urribarri AD, Munoz-Garrido P, Perugorria MJ, Erice O, Merino-Azpitarte M, Arbelaiz A, Lozano E, Hijona E, Jiménez-Agüero R, Fernandez-Barrena MG, Jimeno JP, Marzioni M, Marin JJ, Masyuk TV, LaRusso NF, Prieto J, Bujanda L, Banales JM.
    Gut; 2014 Oct; 63(10):1658-67. PubMed ID: 24436140
    [Abstract] [Full Text] [Related]

  • 24. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.
    Rajagopal S, Kumar DP, Mahavadi S, Bhattacharya S, Zhou R, Corvera CU, Bunnett NW, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar 01; 304(5):G527-35. PubMed ID: 23275618
    [Abstract] [Full Text] [Related]

  • 25. Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.
    Masyuk TV, Lee SO, Radtke BN, Stroope AJ, Huang B, Banales JM, Masyuk AI, Splinter PL, Gradilone SA, Gajdos GB, LaRusso NF.
    Am J Pathol; 2014 Jan 01; 184(1):110-21. PubMed ID: 24211536
    [Abstract] [Full Text] [Related]

  • 26. Development and functional characterization of extrahepatic cholangiocyte lines from normal rats.
    Venter J, Francis H, Meng F, DeMorrow S, Kennedy L, Standeford H, Hargrove L, Wu N, Wan Y, Frampton G, McMillin M, Marzioni M, Gaudio E, Onori P, Glaser S, Alpini G.
    Dig Liver Dis; 2015 Nov 01; 47(11):964-72. PubMed ID: 26277684
    [Abstract] [Full Text] [Related]

  • 27. Somatostatin analogues for treatment of polycystic liver disease.
    Gevers TJ, Drenth JP.
    Curr Opin Gastroenterol; 2011 May 01; 27(3):294-300. PubMed ID: 21191289
    [Abstract] [Full Text] [Related]

  • 28. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
    Barten TRM, Bernts LHP, Drenth JPH, Gevers TJG.
    Expert Opin Ther Targets; 2020 Jun 01; 24(6):589-599. PubMed ID: 32250187
    [Abstract] [Full Text] [Related]

  • 29. TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic β-Cells via a PKA-Dependent Pathway.
    Maczewsky J, Kaiser J, Gresch A, Gerst F, Düfer M, Krippeit-Drews P, Drews G.
    Diabetes; 2019 Feb 01; 68(2):324-336. PubMed ID: 30409782
    [Abstract] [Full Text] [Related]

  • 30. Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.
    Santos-Laso A, Izquierdo-Sanchez L, Rodrigues PM, Huang BQ, Azkargorta M, Lapitz A, Munoz-Garrido P, Arbelaiz A, Caballero-Camino FJ, Fernández-Barrena MG, Jimenez-Agüero R, Argemi J, Aragon T, Elortza F, Marzioni M, Drenth JPH, LaRusso NF, Bujanda L, Perugorria MJ, Banales JM.
    Liver Int; 2020 Jul 01; 40(7):1670-1685. PubMed ID: 32378324
    [Abstract] [Full Text] [Related]

  • 31. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
    Banales JM, Masyuk TV, Bogert PS, Huang BQ, Gradilone SA, Lee SO, Stroope AJ, Masyuk AI, Medina JF, LaRusso NF.
    Am J Pathol; 2008 Dec 01; 173(6):1637-46. PubMed ID: 18988797
    [Abstract] [Full Text] [Related]

  • 32. TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.
    Kaya D, Kaji K, Tsuji Y, Yamashita S, Kitagawa K, Ozutsumi T, Fujinaga Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H.
    Cells; 2019 Sep 26; 8(10):. PubMed ID: 31561561
    [Abstract] [Full Text] [Related]

  • 33. Multi-omics profiling of cholangiocytes reveals sex-specific chromatin state dynamics during hepatic cystogenesis in polycystic liver disease.
    Ji R, Chen J, Xie Y, Dou X, Qing B, Liu Z, Lu Y, Dang L, Zhu X, Sun Y, Zheng X, Zhang L, Guo D, Chen Y.
    J Hepatol; 2023 Apr 26; 78(4):754-769. PubMed ID: 36681161
    [Abstract] [Full Text] [Related]

  • 34. TGR5 in the biliary tree.
    Keitel V, Häussinger D.
    Dig Dis; 2011 Apr 26; 29(1):45-7. PubMed ID: 21691103
    [Abstract] [Full Text] [Related]

  • 35. Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases.
    Sun L, Yu CY, Mackey LV, Coy DH.
    Curr Top Med Chem; 2015 Apr 26; 16(2):133-40. PubMed ID: 26126910
    [Abstract] [Full Text] [Related]

  • 36. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term.
    Keitel V, Spomer L, Marin JJ, Williamson C, Geenes V, Kubitz R, Häussinger D, Macias RI.
    Placenta; 2013 Sep 26; 34(9):810-6. PubMed ID: 23849932
    [Abstract] [Full Text] [Related]

  • 37. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC, Boehme S, Li F, Chiang JY.
    Hepatology; 2017 Mar 26; 65(3):813-827. PubMed ID: 27351453
    [Abstract] [Full Text] [Related]

  • 38. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.
    Onori P, Mancinelli R, Franchitto A, Carpino G, Renzi A, Brozzetti S, Venter J, Francis H, Glaser S, Jefferson DM, Alpini G, Gaudio E.
    Liver Int; 2013 Jul 26; 33(6):914-25. PubMed ID: 23617956
    [Abstract] [Full Text] [Related]

  • 39. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
    Yanguas-Casás N, Barreda-Manso MA, Nieto-Sampedro M, Romero-Ramírez L.
    J Cell Physiol; 2017 Aug 26; 232(8):2231-2245. PubMed ID: 27987324
    [Abstract] [Full Text] [Related]

  • 40. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells.
    Keitel V, Reinehr R, Gatsios P, Rupprecht C, Görg B, Selbach O, Häussinger D, Kubitz R.
    Hepatology; 2007 Mar 26; 45(3):695-704. PubMed ID: 17326144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.